PDE5A
cGMP-specific 3',5'-cyclic phosphodiesterase
Also known as: PDE5A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O76074
- Gene
- PDE5A
- Ensembl
- ENSG00000138735
- Chromosome
- 4
- Canonical length
- 875 aa
- Protein class
- Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Basal body,Cytosol
OverviewNCBI Gene
This gene encodes a cGMP-binding, cGMP-specific phosphodiesterase, a member of the cyclic nucleotide phosphodiesterase family. This phosphodiesterase specifically hydrolyzes cGMP to 5'-GMP. It is involved in the regulation of intracellular concentrations of cyclic nucleotides and is important for smooth muscle relaxation in the cardiovascular system. Alternative splicing of this gene results in three transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
875 residues, UniProt reviewed canonical sequence.
>O76074|PDE5A
1 MERAGPSFGQ QRQQQQPQQQ KQQQRDQDSV EAWLDDHWDF TFSYFVRKAT REMVNAWFAE
61 RVHTIPVCKE GIRGHTESCS CPLQQSPRAD NSAPGTPTRK ISASEFDRPL RPIVVKDSEG
121 TVSFLSDSEK KEQMPLTPPR FDHDEGDQCS RLLELVKDIS SHLDVTALCH KIFLHIHGLI
181 SADRYSLFLV CEDSSNDKFL ISRLFDVAEG STLEEVSNNC IRLEWNKGIV GHVAALGEPL
241 NIKDAYEDPR FNAEVDQITG YKTQSILCMP IKNHREEVVG VAQAINKKSG NGGTFTEKDE
301 KDFAAYLAFC GIVLHNAQLY ETSLLENKRN QVLLDLASLI FEEQQSLEVI LKKIAATIIS
361 FMQVQKCTIF IVDEDCSDSF SSVFHMECEE LEKSSDTLTR EHDANKINYM YAQYVKNTME
421 PLNIPDVSKD KRFPWTTENT GNVNQQCIRS LLCTPIKNGK KNKVIGVCQL VNKMEENTGK
481 VKPFNRNDEQ FLEAFVIFCG LGIQNTQMYE AVERAMAKQM VTLEVLSYHA SAAEEETREL
541 QSLAAAVVPS AQTLKITDFS FSDFELSDLE TALCTIRMFT DLNLVQNFQM KHEVLCRWIL
601 SVKKNYRKNV AYHNWRHAFN TAQCMFAALK AGKIQNKLTD LEILALLIAA LSHDLDHRGV
661 NNSYIQRSEH PLAQLYCHSI MEHHHFDQCL MILNSPGNQI LSGLSIEEYK TTLKIIKQAI
721 LATDLALYIK RRGEFFELIR KNQFNLEDPH QKELFLAMLM TACDLSAITK PWPIQQRIAE
781 LVATEFFDQG DRERKELNIE PTDLMNREKK NKIPSMQVGF IDAICLQLYE ALTHVSEDCF
841 PLLDGCRKNR QKWQALAEQQ EKMLINGESG QAKRNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PDE5A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 56 nTPM
Expression across tissuesHPA
Tissue
- prostate: 56 nTPM
- blood vessel: 55 nTPM
- seminal vesicle: 47 nTPM
- epididymis: 39 nTPM
- esophagus: 39 nTPM
- colon: 35 nTPM
Single-cell type
- cardiomyocytes: 589 nCPM
- platelets: 551 nCPM
- epicardial cells: 498 nCPM
- adipocytes: 362 nCPM
- fibro-adipogenic progenitors: 334 nCPM
- vascular smooth muscle cells: 333 nCPM
Immune cell
- total PBMC: 1.2 nTPM
- MAIT T-cell: 0.7 nTPM
- memory B-cell: 0.5 nTPM
- neutrophil: 0.5 nTPM
- memory CD4 T-cell: 0.4 nTPM
- naive B-cell: 0.4 nTPM
Brain region
- choroid plexus: 37 nTPM
- midbrain: 29 nTPM
- cerebellum: 21 nTPM
- pons: 21 nTPM
- basal ganglia: 19 nTPM
- hypothalamus: 18 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.1
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- 3',5'-cyclic-AMP phosphodiesterase activity
- 3',5'-cyclic-GMP phosphodiesterase activity
- 3',5'-cyclic-nucleotide phosphodiesterase activity
- cGMP binding
- metal ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain
- GAF domain
- HD/PDEase domain
- 3'5'-cyclic nucleotide phosphodiesterase
- 3'5'-cyclic nucleotide phosphodiesterase, conserved site
- GAF-like domain superfamily
- 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain superfamily
- 3'5'-cyclic nucleotide phosphodiesterase
- GAF domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PDE5A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PDE5A as an antibody target. Whether an autoantibody or antibody against PDE5A could matter depends on whether native PDE5A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PDE5A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PDE5A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...